These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 17207021

  • 1. Proteomics analysis in lung cancer: challenges and opportunities.
    Kikuchi T, Carbone DP.
    Respirology; 2007 Jan; 12(1):22-8. PubMed ID: 17207021
    [Abstract] [Full Text] [Related]

  • 2. Current proteomic analysis and post-translational modifications of biomarkers in human lung cancer materials.
    Sinchaikul S, Hongsachart P, Sriyam S, Tantipaiboonwong P, Phutrakul S, Chen ST.
    Chang Gung Med J; 2008 Jan; 31(5):417-30. PubMed ID: 19097588
    [Abstract] [Full Text] [Related]

  • 3. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
    Bharti A, Ma PC, Salgia R.
    Mass Spectrom Rev; 2007 Jan; 26(3):451-66. PubMed ID: 17407130
    [Abstract] [Full Text] [Related]

  • 4. Proteomic approaches in lung cancer biomarker development.
    Cho JY, Sung HJ.
    Expert Rev Proteomics; 2009 Feb; 6(1):27-42. PubMed ID: 19210125
    [Abstract] [Full Text] [Related]

  • 5. Proteomic approaches for serum biomarker discovery in cancer.
    Maurya P, Meleady P, Dowling P, Clynes M.
    Anticancer Res; 2007 Feb; 27(3A):1247-55. PubMed ID: 17593616
    [Abstract] [Full Text] [Related]

  • 6. Oncoproteomics: current trends and future perspectives.
    Cho WC, Cheng CH.
    Expert Rev Proteomics; 2007 Jun; 4(3):401-10. PubMed ID: 17552924
    [Abstract] [Full Text] [Related]

  • 7. Proteomic analysis of bone cancer: a review of current and future developments.
    Bhattacharyya S, Byrum S, Siegel ER, Suva LJ.
    Expert Rev Proteomics; 2007 Jun; 4(3):371-8. PubMed ID: 17552921
    [Abstract] [Full Text] [Related]

  • 8. The molecular make-up of a tumour: proteomics in cancer research.
    Kolch W, Mischak H, Pitt AR.
    Clin Sci (Lond); 2005 May; 108(5):369-83. PubMed ID: 15831087
    [Abstract] [Full Text] [Related]

  • 9. Clinical proteomics in breast cancer: a review.
    Gast MC, Schellens JH, Beijnen JH.
    Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
    [Abstract] [Full Text] [Related]

  • 10. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer.
    Ueda K, Katagiri T, Shimada T, Irie S, Sato TA, Nakamura Y, Daigo Y.
    J Proteome Res; 2007 Sep; 6(9):3475-83. PubMed ID: 17705522
    [Abstract] [Full Text] [Related]

  • 11. Present status of clinical proteomic analysis for the early detection and determination of therapeutic strategy in lung cancer.
    Hirano T, Kato H.
    Ann Thorac Cardiovasc Surg; 2006 Feb; 12(1):4-9. PubMed ID: 16572067
    [Abstract] [Full Text] [Related]

  • 12. Proteomics: new technologies and clinical applications.
    Latterich M, Abramovitz M, Leyland-Jones B.
    Eur J Cancer; 2008 Dec; 44(18):2737-41. PubMed ID: 18977654
    [Abstract] [Full Text] [Related]

  • 13. Advances in ovarian cancer proteomics: the quest for biomarkers and improved therapeutic interventions.
    Jurisicova A, Jurisica I, Kislinger T.
    Expert Rev Proteomics; 2008 Aug; 5(4):551-60. PubMed ID: 18761466
    [Abstract] [Full Text] [Related]

  • 14. Strategies for plasma proteomic profiling of cancers.
    Omenn GS.
    Proteomics; 2006 Oct; 6(20):5662-73. PubMed ID: 16991194
    [Abstract] [Full Text] [Related]

  • 15. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
    Ou K, Yu K, Kesuma D, Hooi M, Huang N, Chen W, Lee SY, Goh XP, Tan LK, Liu J, Soon SY, Bin Abdul Rashid S, Putti TC, Jikuya H, Ichikawa T, Nishimura O, Salto-Tellez M, Tan P.
    J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
    [Abstract] [Full Text] [Related]

  • 16. Proteomics: recent applications and new technologies.
    Elrick MM, Walgren JL, Mitchell MD, Thompson DC.
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):432-41. PubMed ID: 16635100
    [Abstract] [Full Text] [Related]

  • 17. Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers.
    Lee JW, Figeys D, Vasilescu J.
    Adv Cancer Res; 2007 May; 96():269-98. PubMed ID: 17161683
    [Abstract] [Full Text] [Related]

  • 18. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies.
    Kulasingam V, Diamandis EP.
    Nat Clin Pract Oncol; 2008 Oct; 5(10):588-99. PubMed ID: 18695711
    [Abstract] [Full Text] [Related]

  • 19. Gene expression profiling of non-small-cell lung cancer.
    Lacroix L, Commo F, Soria JC.
    Expert Rev Mol Diagn; 2008 Mar; 8(2):167-78. PubMed ID: 18366303
    [Abstract] [Full Text] [Related]

  • 20. Advanced proteomic technologies for cancer biomarker discovery.
    Wong SC, Chan CM, Ma BB, Lam MY, Choi GC, Au TC, Chan AS, Chan AT.
    Expert Rev Proteomics; 2009 Apr; 6(2):123-34. PubMed ID: 19385940
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.